Drug Profile


Alternative Names: TJN 151

Latest Information Update: 21 Oct 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Tsumura
  • Class Anti-inflammatories; Antiallergics; Antirheumatics; Antivirals; Flavonoids; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Hepatitis C; HIV-1 infections

Most Recent Events

  • 31 Dec 2002 Discontinued - Preclinical for HIV-1 infections in China (unspecified route)
  • 22 Aug 2002 Discontinued - Preclinical for Cancer in Japan (unspecified route)
  • 22 Aug 2002 Discontinued - Preclinical for Hepatitis C in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top